Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Jeschke

Showing results (41-50 of 408) with videos related to

Pageof 41
Sort By:
Anticancer Research|June 25, 2003
hCG in trophoblast tumour cells of the cell line Jeg3 and hCG isolated from amniotic fluid and serum of pregnant women carry oligosaccharides of the sialyl Lewis X and sialyl Lewis a typeUdo Jeschke, Renate Stahn, Christoph Goletz, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 8, 2007
Peroxisome proliferator-activated receptors: new players in the field of reproductionBettina Toth, Daniela Hornung, Christoph Scholz, et al.
Archives of Gynecology and Obstetrics|February 27, 2022
Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSINina Rogenhofer, Udo Jeschke, Viktoria von Schönfeldt, et al.
Oncology Letters|September 15, 2016
Influence of VEGFR and LHCGR on endometrial adenocarcinomaAlexandra C Kölbl, Amelie E Birk, Christina Kuhn, et al.
International Journal of Molecular Sciences|June 21, 2017
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsXi Zhang, Simone Hofmann, Brigitte Rack, et al.
Oncology Reports|April 26, 2017
Triple-negative breast cancer: New therapeutic options via signalling transduction cascadesUlrich Andergassen, Alexandra C Kölbl, Jan-Niclas Mumm, et al.
Oncology Reports|December 8, 2004
Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasisIoannis Mylonas, Udo Jeschke, Naim Shabani, et al.
Anticancer Research|July 22, 2005
Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer aloneIoannis Mylonas, Josef Makovitzky, Udo Jeschke, et al.
Histochemistry and Cell Biology|December 20, 2022
Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controlsJulia Knabl, Rebecca Hüttenbrenner, Sven Mahner, et al.
Plos One|February 17, 2018
The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometriumMarlene Heckl, Elisa Schmoeckel, Linda Hertlein, et al.
Pageof 41

Showing results (41-50 of 408) with videos related to

Sort By:
Pageof 41
Anticancer Research|June 25, 2003
hCG in trophoblast tumour cells of the cell line Jeg3 and hCG isolated from amniotic fluid and serum of pregnant women carry oligosaccharides of the sialyl Lewis X and sialyl Lewis a typeUdo Jeschke, Renate Stahn, Christoph Goletz, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 8, 2007
Peroxisome proliferator-activated receptors: new players in the field of reproductionBettina Toth, Daniela Hornung, Christoph Scholz, et al.
Archives of Gynecology and Obstetrics|February 27, 2022
Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSINina Rogenhofer, Udo Jeschke, Viktoria von Schönfeldt, et al.
Oncology Letters|September 15, 2016
Influence of VEGFR and LHCGR on endometrial adenocarcinomaAlexandra C Kölbl, Amelie E Birk, Christina Kuhn, et al.
International Journal of Molecular Sciences|June 21, 2017
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsXi Zhang, Simone Hofmann, Brigitte Rack, et al.
Oncology Reports|April 26, 2017
Triple-negative breast cancer: New therapeutic options via signalling transduction cascadesUlrich Andergassen, Alexandra C Kölbl, Jan-Niclas Mumm, et al.
Oncology Reports|December 8, 2004
Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasisIoannis Mylonas, Udo Jeschke, Naim Shabani, et al.
Anticancer Research|July 22, 2005
Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer aloneIoannis Mylonas, Josef Makovitzky, Udo Jeschke, et al.
Histochemistry and Cell Biology|December 20, 2022
Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controlsJulia Knabl, Rebecca Hüttenbrenner, Sven Mahner, et al.
Plos One|February 17, 2018
The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometriumMarlene Heckl, Elisa Schmoeckel, Linda Hertlein, et al.
Pageof 41